
The wait is over! We are so thrilled to welcome our incoming class of interns to the General Surgery Residency program at @WashUSurgery and @WUSTLmed. Congratulations! We can’t wait to meet you in St. Louis! #MatchDay2024 #Match2024
Alexandra Malarczyk
21 posts

@a_malarczyk
PGY-2 @WashUSurgRes | Poznan University of Medical Sciences @Pums_tweets | @bostoncollege alum | Research @harvardmed @BrighamWomens | aspiring academic surgeon

The wait is over! We are so thrilled to welcome our incoming class of interns to the General Surgery Residency program at @WashUSurgery and @WUSTLmed. Congratulations! We can’t wait to meet you in St. Louis! #MatchDay2024 #Match2024









🚨 Just In - after treating AS with TAVR, future cardiac & noncardiac procedures did NOT incur a survival penalty. Now that's what I call "preop optimization" @BrighamThoracic @TsuyoshiKaneko1 @PinakShahMD @Hirji1987 @BrighamSurgery sciencedirect.com/science/articl…






New study on transcatheter aortic valve implantation found that martial status does not improve survival odds for both sexes. Unlike married men, married women had worse survival than single/widowed women @paige_newellMD @TsuyoshiKaneko1 @BrighamSurgery ajconline.org/article/S0002-…

Outstanding and timely study by @paige_newellMD from @BrighamThoracic @BrighamSurgery. @TSRA_official @tssmn @STS_CTsurgery @AATSED @ACCMass @ACCinTouch @BrighamFellows @hrmallidi @DLBHATTMD #TAVR @MorganHarloff @a_malarczyk

🔥Just in @crfshj @TsuyoshiKaneko1 and I explore the concept of 'July effect' in the context of #TAVR and #MitraClip - important findings with regard to resident/fellow training and autonomy @CherylZoggPhD @OkohMd @PinakShahMD @emefahloccoh @a_malarczyk tinyurl.com/59fw2y4n













2/3 We are excited to announce @TSRA_official ‘s new executives for the next year. Thank you for your dedication and all the hard work in the background! New Executives: Christina Constantino, Irbaz Hameed, Anna Olds, Sameer Hirji.

In this analysis of @CMSGov data, repeat #TAVR was associated w/ ⬇️ 30-day mortality & MACE compared to TAVR explanation. At 1-year, mortality was similar between both groups. bit.ly/37Fw5GO #JACCINT #CardioTwitter @PinakShahMD @DLBHATTMD @GilbertTangMD @TsuyoshiKaneko1

Great #JACCIntv @jaccjournals paper with my friend @TsuyoshiKaneko1 et al on redo #TAVR vs #TAVR explant from CMS data. Redo TAVR safer than explant in select pts. Need more data and longer-term data. @LandesUri @Hirji1987 @NimeshDesaiMD @djc795 jacc.org/doi/10.1016/j.…